Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib-Reference-Cited by-同舟云学术

Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib

Published:2019-04-09 Issue:9 Volume:62 Page:4444-4455
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Lee Min Jae¹,Bhattarai Deepak¹,Yoo Jisu²,Miller Zach¹,Park Ji Eun²,Lee Sukyeong³,Lee Wooin²,Driscoll James J.⁴,Kim Kyung Bo¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky 40536, United States

2. College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Korea

3. Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, United States

4. Department of Internal Medicine, Division of Hematology and Oncology and University of Cincinnati Cancer Institute, Cincinnati, Ohio 45267, United States

Funder

Seoul National University

National Institute of General Medical Sciences

Ministry of Health and Welfare

National Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b01943

Reference50 articles.

1. Where We Were, Where We Are, Where We Are Going: Progress in Multiple Myeloma

2. Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives

3. Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma

4. Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial

5. Hallmarks of Cancer: The Next Generation

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Novel Nonpeptidic Proteasome Inhibitors Using Covalent Virtual Screening and Biological Evaluation;ACS Medicinal Chemistry Letters;2024-09-09

2. Primed for Interactions: Investigating the Primed Substrate Channel of the Proteasome for Improved Molecular Engagement;Molecules;2024-07-17

3. Brain-Derived 11S Regulator (PA28αβ) Promotes Proteasomal Hydrolysis of Elongated Oligoglutamine-Containing Peptides;International Journal of Molecular Sciences;2023-08-26

4. Simultaneous Covalent Modification of K-Ras(G12D) and K-Ras(G12C) with Tunable Oxirane Electrophiles;Journal of the American Chemical Society;2023-08-03

5. Influence of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments;International Journal of Molecular Sciences;2023-05-30